» Articles » PMID: 25308416

Potential Deleterious Role of Anti-Neu5Gc Antibodies in Xenotransplantation

Overview
Specialty General Surgery
Date 2014 Oct 14
PMID 25308416
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Human beings do not synthesize the glycolyl form of the sialic acid (Neu5Gc) and only express the acetylated form of the sugar, whereas a diet-based intake of Neu5Gc provokes a natural immunization and production of anti-Neu5Gc antibodies in human serum. However, Neu5Gc is expressed on mammal glycoproteins and glycolipids in most organs and cells. We review here the relevance of Neu5Gc and anti-Neu5Gc antibodies in the context of xenotransplantation and the use of animal-derived molecules and products, as well as the possible consequences of a long-term exposure to anti-Neu5Gc antibodies in recipients of xenografts. In addition, the importance of an accurate estimation of the anti-Neu5Gc response following xenotransplantation and the future contribution of knockout animals mimicking the human situation are also assessed.

Citing Articles

Surveillance and prevention of infection in clinical xenotransplantation.

Stewart A, Fishman J Clin Microbiol Rev. 2025; 38(1):e0015023.

PMID: 39887237 PMC: 11905366. DOI: 10.1128/cmr.00150-23.


Cardiac Xenotransplantation: a New Frontier for Advanced Heart Failure.

Montgomery R, Tang W Curr Treat Options Cardiovasc Med. 2024; 25(3):65-78.

PMID: 38957658 PMC: 11218470. DOI: 10.1007/s11936-023-00977-6.


How should cardiac xenotransplantation be initiated in Japan?.

Saito S, Miyagawa S, Kawamura T, Yoshioka D, Kawamura M, Kawamura A Surg Today. 2024; 54(8):829-838.

PMID: 38733536 PMC: 11266268. DOI: 10.1007/s00595-024-02861-7.


LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation.

Rousse J, Royer P, Evanno G, Lheriteau E, Ciron C, Salama A Front Immunol. 2023; 14:1137629.

PMID: 36875084 PMC: 9978386. DOI: 10.3389/fimmu.2023.1137629.


Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine.

Kasravi M, Ahmadi A, Babajani A, Mazloomnejad R, Hatamnejad M, Shariatzadeh S Biomater Res. 2023; 27(1):10.

PMID: 36759929 PMC: 9912640. DOI: 10.1186/s40824-023-00348-z.